Physician visits prior to treatment for clinically localized prostate cancer. - Wikidata - awgldk - TriplyDB

Physician visits prior to treatment for clinically localized prostate cancer.

Physician visits prior to treatment for clinically localized prostate cancer.

http://www.wikidata.org/entity/Q34610617

about

Low-dose rate brachytherapy for men with localized prostate cancer A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications Provider continuity prior to the diagnosis of advanced lung cancer and end-of-life care.Surgical quality is more than volume: the association between changing urologists and complications for patients with localized prostate cancer.Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience.Impact of age at diagnosis on prostate cancer treatment and survival Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population.Locoregional prostate cancer treatment pattern variation in independent cancer centers: policy effect, patient preference, or physician incentive?Decision aids for localized prostate cancer treatment choice: Systematic review and meta-analysis.Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse Shared decision making in oncology practice: what do oncologists need to know?Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer.Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.High-risk prostate cancer-classification and therapy.Influence of primary care on breast cancer outcomes among Medicare beneficiaries The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience.Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment program Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC).Why do patients regret their prostate cancer treatment? A systematic review of regret after treatment for localized prostate cancer.The impact of county-level radiation oncologist density on prostate cancer mortality in the United States.Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes.Perineal discomfort in prostatic adenocarcinoma.Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study.Clinical profile, quality of care, and recurrence in Arab-American and Caucasians prostate cancer patients in Michigan.Prostate Cancer Care Before and After Medicare Eligibility.When Primary Care Providers (PCPs) Help Patients Choose Prostate Cancer Treatment.Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer.Variation in prostate cancer treatment associated with population density of the county of residence.Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.Multidisciplinary Oncology Education: Going Beyond Tumor Board.Information needs of early-stage prostate cancer patients: within- and between-group agreement of patients and health professionals.Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.

P2860

Q24235544-FD20CCFF-0A36-4C57-8E65-5864FC07BFF7 Q28652628-3911C783-BE4C-4FBA-B1E0-F59B18644487 Q30417174-61A9A7CD-7804-478A-AD0B-DC9CA4858391 Q31138079-EC86C5C4-BA68-4F1A-9EF6-5EFBD3D1AC89 Q33946732-EED29E35-FCFC-4B65-8AAD-D33C8A7F7B70 Q34335177-AA6D966B-2362-4919-A414-D8CA88E8807D Q34679220-0FCE8E8F-51D6-495E-9370-24C9A073E0C2 Q34696349-5ABE15E1-1178-41D9-875B-96D93065D8FF Q35114920-DC94AFFE-DB1F-4F12-B69B-BAF89E7059E1 Q35459197-BA8CAC4B-2FB7-4865-9C2D-AB068D97CBDC Q35577609-9652DB20-51FA-4E7D-8E83-8C4285B3A31C Q35602510-C98C1DE0-E143-4883-8405-4DD2452DFAAB Q35705334-AF780F1D-B4AE-45E7-88FE-4B3C8C1C678E Q35743202-12ABF1B3-FE1C-4C5D-AE87-6004A876851C Q35819651-305CAFDF-D6DA-430A-B517-3A2323F44C29 Q35869811-9B0BE178-B1F3-4A97-B569-CAEEBCE60C0E Q36222876-E21C24A8-4FFE-469A-926D-FCD259646678 Q36290824-3071BA74-675B-4BA9-B3D4-1AB310FA1B40 Q36520523-5EE52DCE-8AF9-4EFA-96D7-BDD4DA89D2C4 Q36520534-909CC995-8A88-4670-BCF4-3F84AC3087FA Q36522791-D8E385E9-B5F1-4F2C-8EE7-AFE570B5336F Q36534788-32482FCB-F5AF-4BDF-9681-0310C20FC9B9 Q36776998-25FD6D00-3397-493F-94DC-F737393BD7DE Q36823071-8B1BE47A-09D4-4E1D-81BF-1B2C6DE1B4FE Q36905270-16753DD9-E010-4573-9867-A9E11662D524 Q38019954-AC095E03-A6D2-4CF0-B4BB-CD1E6398711D Q38366517-9B9FD2CE-37E5-4A12-BDD8-35E09F7032E8 Q38414986-58B7021F-3570-439E-8CD3-EFE7D2A20E72 Q38432682-449FD69D-E02E-411A-9F62-85846C5C8AC2 Q39023568-FAAA55CB-6307-4C66-996A-292AAAF97B88 Q39400229-EA0596EB-94AB-4917-BCA4-25EF0AA10385 Q39591491-1A4ECECF-7074-4C01-9937-6F14A86FAC47 Q39776492-ED2B2AB4-0AFF-4776-B3E2-440FCE613CFD Q40209684-DD88F985-00CA-4182-9126-9F542A0273FB Q40732738-CD196A10-90D0-4375-A27F-69C1A9FD6F08 Q40967147-6654E200-264A-4FCF-9DCF-9FDAB203CFE4 Q41141658-CC03D564-6370-4D40-ACAF-3294C97C7511 Q41645248-077D9F63-7676-4345-97F3-B127DA12BD95 Q41814411-4AF079A2-8748-4AB3-92AB-67A918B3C6B7 Q42265374-1A96DFF9-9472-4F32-B561-464F25D04595

P2860

Physician visits prior to treatment for clinically localized prostate cancer.

http://www.wikidata.org/entity/Q34610617

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Physician visits prior to treatment for clinically localized prostate cancer.

@ast

Physician visits prior to treatment for clinically localized prostate cancer.

@en

Physician visits prior to treatment for clinically localized prostate cancer.

@nl

type

label

Physician visits prior to treatment for clinically localized prostate cancer.

@ast

Physician visits prior to treatment for clinically localized prostate cancer.

@en

Physician visits prior to treatment for clinically localized prostate cancer.

@nl

prefLabel

Physician visits prior to treatment for clinically localized prostate cancer.

@ast

Physician visits prior to treatment for clinically localized prostate cancer.

@en

Physician visits prior to treatment for clinically localized prostate cancer.

@nl

P1433

Q34610617-A0EAF8B2-D136-4AB0-89BF-CF1B883491B2

P1476

Q34610617-AE8BC426-EB58-4BCC-8798-CC301B489A88

P2093

Q34610617-03C37EDC-BFF2-4350-8A8C-60294FD6E2E6

Q34610617-051BFD95-4BBC-434F-A27E-3846EF092CF6

Q34610617-409300E4-0668-4453-A432-991C8FE2D6B2

Q34610617-4F42E73E-DD5A-414F-8440-A11798A0E281

Q34610617-6DF799C3-0715-4D56-BF33-D17C1B49F02F

Q34610617-72D2351B-336C-4497-9991-0781D257300B

Q34610617-8C1706BE-52B8-4278-BF05-9FFD210CC313

Q34610617-92CE8121-F7FE-4AE7-B9BB-D9293A849B72

Q34610617-DE31EADA-695C-4FB4-B118-24D21C8460BC

P2860

Q34610617-0BFA32FE-BC09-44F8-BBA4-3BD46D936462

Q34610617-279B944E-04E6-4535-8827-CAB32D0FED64

Q34610617-5CABD6D3-D69A-48EC-A372-6DABB888745C

Q34610617-71A17198-FA40-437A-AB1D-BEA9A504BB8E

Q34610617-759122BD-6598-4085-8C91-81552A0DB797

Q34610617-8A4A6A7D-A0AD-49B4-B62F-82F8F1912C9C

Q34610617-97B2EFD1-AE38-4EEE-A978-C945B703D510

Q34610617-9B49FCAF-A67A-49DE-A76C-64E56CDC6383

Q34610617-E67389A6-2515-4743-84A2-1E7A536AB68C

Q34610617-F1854F35-0497-4C9B-814F-15B0CEC160C0

P304

Q34610617-99A83CD6-93EE-4126-967F-D4F5E5D67BBB

P31

Q34610617-454ED942-DD97-424B-ABA0-6572D3CC6264

P356

Q34610617-BCB4D5C7-4F23-49AC-B130-E89AD2A16BF2

P407

Q34610617-92F42B18-3047-4DA5-A2E4-0B7489B7B2EE

P433

Q34610617-FE443114-37C6-4E10-9F22-B1911847E401

P478

Q34610617-5430D9AB-6049-42B8-A9A6-0709EB1B62E0

P50

Q34610617-5CAA4928-9E98-4242-92E9-42D3B4A563BD

P577

Q34610617-D566BF04-FC61-4B10-9B63-D51412BF9168

P5875

Q34610617-E446269C-BD63-412A-84BE-46A3A901B48D

P698

Q34610617-C7C7B3AD-CBCB-4C25-A077-AF17CB530E90

P932

Q34610617-5A77277D-91E9-4359-9E19-CCCA7236FBF3

P356

ARCHINTERNMED.2010.1

P1433

JAMA Internal Medicine

P1476

Physician visits prior to treatment for clinically localized prostate cancer

@en

P2093

Colin B Begg

http://www.w3.org/2001/XMLSchema#string

Deborah Schrag

http://www.w3.org/2001/XMLSchema#string

Elena B Elkin

http://www.w3.org/2001/XMLSchema#string

Ethan M Basch

http://www.w3.org/2001/XMLSchema#string

Justin E Bekelman

http://www.w3.org/2001/XMLSchema#string

Peter B Bach

http://www.w3.org/2001/XMLSchema#string

Peter T Scardino

http://www.w3.org/2001/XMLSchema#string

Thomas L Jang

http://www.w3.org/2001/XMLSchema#string

Yihai Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

Development of a comorbidity index using physician claims data.

Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement.

Radical prostatectomy versus watchful waiting in early prostate cancer.

Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer.

Assessing quality using administrative data.

The effect of clustering of outcomes on the association of procedure volume and surgical outcomes.

Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists.

Potential for cancer related health services research using a linked Medicare-tumor registry database.

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

P304

440-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/ARCHINTERNMED.2010.1

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

170

http://www.w3.org/2001/XMLSchema#string

P50

Michael J Zelefsky

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41825559

http://www.w3.org/2001/XMLSchema#string

P698

20212180

http://www.w3.org/2001/XMLSchema#string

P932

4251764

http://www.w3.org/2001/XMLSchema#string